• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2020-2021 年圣保罗市 SARS-CoV-2 感染的流行演变。

Prevalence evolution of SARS-CoV-2 infection in the city of São Paulo, 2020-2021.

机构信息

Secretaria Municipal de Saúde. Coordenadoria de Vigilância em Saúde.São Paulo, SP, Brasil.

Universidade de São Paulo. Faculdade de Saúde Pública. São Paulo, SP, Brasil.

出版信息

Rev Saude Publica. 2021 Oct 22;55:62. doi: 10.11606/s1518-8787.2021055003970. eCollection 2021.

DOI:10.11606/s1518-8787.2021055003970
PMID:34706038
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8522737/
Abstract

OBJECTIVE

To estimate the evolution of the prevalence of SARS-CoV-2 virus infection among residents aged 18 years or over in the municipality of São Paulo.

METHODS

This is a population-based household survey conducted every 15 days, between June and September 2020, and January and February 2021. In total, the study comprised 11 phases. The presence of antibodies against SARS-CoV-2 was identified in venous blood using a lateral flow test, Wondfo Biotech. In the last phase, the researchers combined it with an immunoenzymatic test, Euroimmun. The participants also answered a semi-structured questionnaire on sociodemographic and economic factors, and on social distancing measures. Prevalence estimates and the 95% confidence interval were estimated according to regions, Human Development Index, sex, age group, ethnicity, education, income, and variables associated with risk or prevention of infection. To compare the frequencies among the categories of each variable, the chi-square test with Rao-Scott correction was used, considering a significance level of 5%.

RESULTS

In total, 23,397 individuals were interviewed and had their samples collected. The estimated prevalence of antibodies against SARS-CoV-2 ranged from 9.7% (95%CI: 7.9-11.8%) to 25.0% (95%CI: 21.7-28.7). The prevalence of individuals with antibodies against the virus was higher among black and brown people, people with lower schooling and income, and among residents of regions with lower Human Development Index. The lowest prevalences were associated with recommended measures of disease protection. The proportion of asymptomatic infection was 45.1%.

CONCLUSION

The estimated prevalence of the infection was lower than the cumulative incidence variation, except for the last phase of the study. The differences in prevalence estimates observed among subpopulations showed social inequality as a risk of infection. The lower prevalence observed among those who could follow prevention measures reinforce the need to maintain social distancing measures as a way to prevent SARS-CoV-2 infection.

摘要

目的

估计 18 岁及以上圣保罗市居民中 SARS-CoV-2 病毒感染的流行率演变情况。

方法

这是一项基于人群的家庭调查,于 2020 年 6 月至 9 月和 2021 年 1 月至 2 月期间每 15 天进行一次。该研究共包括 11 个阶段。使用侧向流动试验(Wondfo Biotech)在静脉血中检测 SARS-CoV-2 抗体的存在。在最后一个阶段,研究人员将其与免疫酶试验(Euroimmun)相结合。参与者还回答了一个关于社会人口经济学因素和社会隔离措施的半结构化问卷。根据地区、人类发展指数、性别、年龄组、种族、教育、收入以及与感染风险或预防相关的变量,估计了流行率估计值和 95%置信区间。为了比较每个变量类别之间的频率,使用了具有 Rao-Scott 校正的卡方检验,置信水平为 5%。

结果

共采访了 23397 人并采集了样本。估计的 SARS-CoV-2 抗体流行率范围为 9.7%(95%CI:7.9-11.8%)至 25.0%(95%CI:21.7-28.7%)。病毒抗体阳性者中,黑人和棕色人种、受教育程度和收入较低的人群以及人类发展指数较低地区的居民的患病率较高。与疾病保护推荐措施相关的最低患病率。无症状感染的比例为 45.1%。

结论

除研究的最后阶段外,估计的感染流行率低于累积发病率的变化。观察到的亚人群之间的流行率估计差异表明,社会不平等是感染的风险因素。在能够遵循预防措施的人群中观察到的较低流行率,强调了保持社会距离措施作为预防 SARS-CoV-2 感染的一种方式的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e255/8522737/141d42012ab7/1518-8787-rsp-55-62-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e255/8522737/f158cda93d56/1518-8787-rsp-55-62-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e255/8522737/141d42012ab7/1518-8787-rsp-55-62-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e255/8522737/f158cda93d56/1518-8787-rsp-55-62-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e255/8522737/141d42012ab7/1518-8787-rsp-55-62-gf02.jpg

相似文献

1
Prevalence evolution of SARS-CoV-2 infection in the city of São Paulo, 2020-2021.2020-2021 年圣保罗市 SARS-CoV-2 感染的流行演变。
Rev Saude Publica. 2021 Oct 22;55:62. doi: 10.11606/s1518-8787.2021055003970. eCollection 2021.
2
Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil.巴西圣保罗市受影响最严重地区 SARS-CoV-2 初始血清流行率评估。
Braz J Infect Dis. 2021 Jul-Aug;25(4):101604. doi: 10.1016/j.bjid.2021.101604. Epub 2021 Aug 10.
3
Seroprevalence of SARS-CoV-2 antibodies in schoolchildren in the city of São Paulo, 2020.2020 年圣保罗市儿童血清新型冠状病毒抗体阳性率。
Rev Saude Publica. 2023 May 26;57(suppl 1):6s. doi: 10.11606/s1518-8787.2023057004782. eCollection 2023.
4
[Prevalence of SARS-CoV-2 antibodies in the State of Mato Grosso, Brazil: a population-based survey].[巴西马托格罗索州严重急性呼吸综合征冠状病毒2抗体的流行情况:一项基于人群的调查]
Cad Saude Publica. 2022 Jun 8;38(5):e00093021. doi: 10.1590/0102-311XPT093021. eCollection 2022.
5
High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort.在巴西玛瑙斯市第二波疫情之前,高抗严重急性呼吸综合征冠状病毒 2 抗体血清转化率,以及社会行为措施的保护作用:前瞻性 DETECTCoV-19 队列研究结果。
Lancet Glob Health. 2021 Nov;9(11):e1508-e1516. doi: 10.1016/S2214-109X(21)00355-7.
6
High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil.巴西圣保罗一家大型大学附属医院出现症状的医护人员中 SARS-CoV-2 感染的高流行率。
BMC Infect Dis. 2020 Dec 2;20(1):917. doi: 10.1186/s12879-020-05662-8.
7
Prevalence of anti-SARS-CoV-2 antibodies in outpatients of a large public university hospital in Sao Paulo, Brazil.巴西圣保罗一所大型公立大学医院门诊患者中抗SARS-CoV-2抗体的流行情况。
Rev Inst Med Trop Sao Paulo. 2020 Nov 13;62:e91. doi: 10.1590/S1678-9946202062091. eCollection 2020.
8
Population-level seropositivity trend for SARS-Cov-2 in Rio Grande do Sul, Brazil.巴西南里奥格兰德州 SARS-CoV-2 人群血清阳性趋势。
Rev Saude Publica. 2021 Nov 22;55:78. doi: 10.11606/s1518-8787.2021055004075. eCollection 2021.
9
Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.巴西东南部里贝朗普雷图人群中 SARS-CoV-2 感染的病毒学和血清学标志物流行情况:一项流行病学调查。
Rev Soc Bras Med Trop. 2021 Jul 2;54:e02102021. doi: 10.1590/0037-8682-0210-2021. eCollection 2021.
10
Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study.康涅狄格州成年人中 SARS-CoV-2 特异性 IgG 抗体的血清流行率:感染后流行率(PIP)研究。
Am J Med. 2021 Apr;134(4):526-534.e11. doi: 10.1016/j.amjmed.2020.09.024. Epub 2020 Oct 29.

引用本文的文献

1
Seroprevalence trends of anti-SARS-CoV-2 antibodies in the adult population of the São Paulo Municipality, Brazil: Results from seven serosurveys from June 2020 to April 2022. The SoroEpi MSP Study.巴西圣保罗市成年人中抗 SARS-CoV-2 抗体的血清流行率趋势:2020 年 6 月至 2022 年 4 月进行的七项血清学调查结果。SoroEpi MSP 研究。
PLoS One. 2024 Aug 26;19(8):e0309441. doi: 10.1371/journal.pone.0309441. eCollection 2024.
2
Parity of esteem: A global COVID-19 vaccination approach for people with mental illnesses, based on facts from 34 countries; recommendations and solutions.同等重视:基于34个国家的事实,为精神疾病患者制定的全球新冠疫苗接种方法;建议与解决方案
Ind Psychiatry J. 2024 Jan-Jun;33(1):30-40. doi: 10.4103/ipj.ipj_54_22. Epub 2023 Dec 14.
3

本文引用的文献

1
High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2.巴西 SARS-CoV-2 抗体阳性者症状高发。
Sci Rep. 2021 Jun 24;11(1):13279. doi: 10.1038/s41598-021-92775-y.
2
SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy).意大利托斯卡纳大区普拉托省全面封锁阶段参与不同必要活动人群的新冠病毒血清流行率调查
Vaccines (Basel). 2020 Dec 19;8(4):778. doi: 10.3390/vaccines8040778.
3
Population-based seroprevalence of SARS-CoV-2 and the herd immunity threshold in Maranhão.
Seroprevalence of SARS-CoV-2 in Brazil: A systematic review and meta-analysis.巴西人群中 SARS-CoV-2 血清抗体流行率的系统评价和荟萃分析。
Clinics (Sao Paulo). 2023 Jun 13;78:100233. doi: 10.1016/j.clinsp.2023.100233. eCollection 2023.
4
Seroprevalence of SARS-CoV-2 antibodies in schoolchildren in the city of São Paulo, 2020.2020 年圣保罗市儿童血清新型冠状病毒抗体阳性率。
Rev Saude Publica. 2023 May 26;57(suppl 1):6s. doi: 10.11606/s1518-8787.2023057004782. eCollection 2023.
5
Seroepidemiology of SARS-CoV-2 on a partially vaccinated island in Brazil: Determinants of infection and vaccine response.巴西部分接种疫苗岛屿上的 SARS-CoV-2 血清流行病学:感染和疫苗反应的决定因素。
Front Public Health. 2022 Nov 14;10:1017337. doi: 10.3389/fpubh.2022.1017337. eCollection 2022.
基于人群的 SARS-CoV-2 血清流行率和马拉尼昂州的群体免疫阈值。
Rev Saude Publica. 2020 Dec 14;54:131. doi: 10.11606/s1518-8787.2020054003278. eCollection 2020.
4
Spatiotemporal ecological study of COVID-19 mortality in the city of São Paulo, Brazil: Shifting of the high mortality risk from areas with the best to those with the worst socio-economic conditions.巴西圣保罗市 COVID-19 死亡率的时空生态研究:高死亡率风险从社会经济条件最好的地区转移到最差的地区。
Travel Med Infect Dis. 2021 Jan-Feb;39:101945. doi: 10.1016/j.tmaid.2020.101945. Epub 2020 Dec 2.
5
Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China.中国武汉 SARS-CoV-2 抗体血清阳性率。
JAMA Netw Open. 2020 Oct 1;3(10):e2025717. doi: 10.1001/jamanetworkopen.2020.25717.
6
SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.巴西的 SARS-CoV-2 抗体流行率:两项连续全国血清学家庭调查结果。
Lancet Glob Health. 2020 Nov;8(11):e1390-e1398. doi: 10.1016/S2214-109X(20)30387-9. Epub 2020 Sep 23.
7
High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts.马萨诸塞州切尔西的 SARS-CoV-2 抗体高血清阳性率。
J Infect Dis. 2020 Nov 13;222(12):1955-1959. doi: 10.1093/infdis/jiaa579.
8
Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York.纽约 SARS-CoV-2 感染的累积发病率和诊断。
Ann Epidemiol. 2020 Aug;48:23-29.e4. doi: 10.1016/j.annepidem.2020.06.004. Epub 2020 Jun 17.
9
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.西班牙 2020 年人群血清流行病学研究(ENE-COVID):全国范围内基于人群的血清流行病学研究。
Lancet. 2020 Aug 22;396(10250):535-544. doi: 10.1016/S0140-6736(20)31483-5. Epub 2020 Jul 6.
10
Molecular and Serological Tests for COVID-19 a Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics.新型冠状病毒肺炎的分子和血清学检测:严重急性呼吸综合征冠状病毒2实验室诊断与即时检测的比较综述
Diagnostics (Basel). 2020 Jun 26;10(6):434. doi: 10.3390/diagnostics10060434.